Senior insider sale
President and CEO at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$41.09M
300K shares
What this filing means
PATEL DINESH V PH D plans to sell 300K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $41.09M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/10/2026ACC: 0001968582-26-000805
DirectorOfficer· President and CEO
Since Jul 2018
300K
Shares to sell
$41.09M
Approx. market value
225K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Option Exercise
Cash
8/10/2026
225KTotal acquired225K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/10/2026 | Option Exercise Cash | 225K | — |
| Total | 225K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
75K
Market value
$7.51M
5/12/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
225K
Market value
$33.58M
8/10/2026
Total
Units
300K
Value
$41.09M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/12/2026 | 75K | $7.51M | — | Completed |
| Planned — Approximate Date | ||||
8/10/2026 | 225K | $33.58M | Nasdaq | Planned |
| Total | 300K | $41.09M | ||